Event & Product News

Perfect Gx Elite vials presented by Gerresheimer at CPhI Worldwide

Düsseldorf/Frankfurt, September 25, 2017. The Gx Elite vials have -set new standards for type 1 borosilicate glass vials. They are the result of comprehensive optimization measures in the conversion process, which have focused on designing out the risk to create product flaws during production including the removal of all  glass-to-glass contact beginning with the tubing material all the way through final packaging. The chemical composition of the bo-rosilicate glass is still the same. Gerresheimer will be showcasing Gx Elite vials at booth D02 in Hall 4.2 at CPhI Worldwide in Frankfurt (Germany) from October 24 to 26, 2017.

The best in its class

“Our Gx Elite vials are setting new standards when it comes to quality,” says Jens Heymann, Senior Vice President Europe & Asia Tubular Glass at Gerresheimer, underlining the major difference that avoiding glass-to-glass contact in the production process can have on vial quality. The highly shatter-resistant vials are extremely durable and free of cosmetic defects. They also boast an incredibly robust structure, while their resistance to delamination protects the drug inside. Simple handling and a range of packaging options ensure that Gx Elite vials can be supplied for end-to-end use on various filling lines. For customers, this means lower costs and higher quality. 

Perfect Gx Elite vials presented by Gerresheimer  at CPhI Worldwide
Perfect Gx Elite vials presented by Gerresheimer at CPhI Worldwide

Intelligent defect recognition

All of Gerresheimer’s tubular glass plants that produce vials work with standardized¬ monitoring, inspection, and packaging technologies, which essentially comprise the Gx G3 and Gx RHOC systems. The inspection systems, for one, are developed in house and form part of a close-knit testing system¬ that ensures the highest precision and quality assurance in line with the latest standards. Complete with five HD cameras, the Gx G3 inspection system makes sure that cosmetic defects are identified reliably, for instance. The intelligent software detects and classifies the defects in a few fractions of a¬ second, while the Gx RHOC system en-sures dimensional quality with three HD matrix cameras on each side and a hypercentric ID camera. 

Injection vials set the benchmark for primary packaging for parenteral drugs. Gerresheimer’s come in all sizes and comply with the relevant international standards and pharmacopoeias (EU, USP, JP). The com-pany’s range includes solutions for bioengineered¬ drugs and other spe-cialist pharmaceuticals¬.

More info

About Gerresheimer

Gerresheimer is a leading global partner to the pharma and healthcare industry. With specialty glass and plastic products, the Company con-tributes to health and well-being. Gerresheimer operates worldwide and its approximately 10,000 employees manufacture products in local mar-kets, close to its customers. With our plants in Europe, North America, South America, and Asia, we generate revenues of approximately EUR 1.4 billion. The company’s comprehensive product portfolio includes pharmaceutical packaging and products for the safe, simple administra-tion of medicines: insulin pens, inhalers, prefillable syringes, injection vials, ampoules, bottles and containers for liquid and solid medicines with closure and safety systems as well as packaging for the cosmetics industry.

Contact